Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 12/8/2020
SIETES contiene 93083 citas

 
 
 1 a 20 de 63 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita originalTiene citas relacionadas Cita con resumen
Moynihan R, MacDonald H, Bero L, Godlee F. Commercial influence and covid-19. BMJ 2020;369:24 de junio. [Ref.ID 103680]
2. Cita con resumen
Moynihan R, Albarqouni L, Nangla C, Dunn AG+, Lexchin J, Bero L. Financial ties between leaders of influential US professional medical associations and industry: cross sectional study. BMJ 2020;369:27 de mayo. [Ref.ID 103650]
3. Cita con resumen
Moynihan R. Evening the score on sex drugs: feminist movement or marketing masquerade?. BMJ 2014;349:g6246. [Ref.ID 98287]
4. Cita con resumen
Moynihan R. Was zanamivir a breakthrough or money for old rope?. BMJ 2014;348:g3611. [Ref.ID 98030]
5.Enlace a cita original
Moynihan R, Henry D, Moons KGM. Using evidence to combat overdiagnosis and overtrea tests, and disease definitions in the time of too much. PLOS Medicine 2014;11:e1001655. [Ref.ID 97789]
6. Cita con resumen
Moynihan R. Act now to fight chronic procrastination disorder. BMJ 2013;347:24. [Ref.ID 96475]
7. Cita con resumen
Moynihan R, Glassock R, Doust J. Chronic kidney disease. How expanding definitions are unnecessarily labelling too many people as diseased. BMJ 2013;347:19-22. [Ref.ID 96159]
8.Enlace a cita original Cita con resumen
Moynihan R. What is disease? And why it's a healthy question. BMJ 2013;346:26. [Ref.ID 94762]
9. Cita con resumen
Moynihan R. Surrogates under scrutiny: fallible correlations, fatal consequences. BMJ 2011;343:d5160. [Ref.ID 91893]
10. Cita con resumen
Moynihan R. Drug firm launches legal action against government advisers. BMJ 2010;341:1071. [Ref.ID 89690]
11.Tiene citas relacionadas Cita con resumen
Moynihan R. Merging of marketing and medical science. BMJ 2010;341:698-700. [Ref.ID 89454]
12.Enlace a cita original Cita con resumen
Moynihan R. Who benefits from treating prehypertension?. BMJ 2010;341:484-5. [Ref.ID 89341]
13.Tiene citas relacionadas Cita con resumen
Moynihan R. Australia says no to seasonal flu jab for healthy under 5s. BMJ 2010;340:1265. [Ref.ID 88675]
14.
Moynihan R. FDA panel to assess drug for low sexual desire in women. BMJ 2010;340:1161. [Ref.ID 88626]
15.Tiene citas relacionadas Cita con resumen
Moynihan R. Rosiglitazone, marketing, and medical science. BMJ 2010;340:785-9. [Ref.ID 88310]
16. Cita con resumen
Moynihan R. US drug manufacturers will have to disclose payments to doctors. BMJ 2010;340:671. [Ref.ID 88184]
17. Cita con resumen
Moynihan R. Psychiatrists aim to redefine female sexual dysfunction. BMJ 2010;340:335. [Ref.ID 87827]
18. Cita con resumen
Moynihan R. Battle over Fosamax bursts into court. BMJ 2009;339:320-1. [Ref.ID 86480]
19.Enlace a cita original
D'Arcy E, Moynihan R. Can the relationship between doctors and drug companies ever be a healthy one?. PLOS Medicine 2009;6:75. [Ref.ID 86424]
20.Tiene citas relacionadas Cita con resumen
Moynihan R. Publisher apologises for fake journal sponsored by Merck. BMJ 2009;338:1164. [Ref.ID 85891]
Seleccionar todas
 
 1 a 20 de 63 siguiente >>